News brief
On 2026/5/29, Xiniu Data reported that BIOYOND completed equity financing for an undisclosed amount. Investors were Chengdu Panlin Hongkang Venture Capital Partnership (Limited Partnership), CICC Qide Xinyi (Guangzhou) Venture Capital Partnership (Limited Partnership), and Ruifudi Biomedical (Shanghai) Co., Ltd. The company provides AI-powered autonomous laboratory solutions.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年5月29日，据烯牛数据报道，奔曜科技完成股权投资融资，金额未披露。投资方为成都磐霖弘康创业投资合伙企业（有限合伙）、中金启德新医（广州）创业投资合伙企业（有限合伙）、瑞孚迪生物医学（上海）有限公司。该公司为AI驱动自主实验室解决方案提供商。